UB Paderborn / Katalog / Suche / in CDI

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

1 – 25 von 1.281

Sortiert nach

Inter-cellular CRISPR screens reveal regulators of cancer cell phagocytosis

Nature (London), 2021-09, Vol.597 (7877), p.549-554

2021

Volltextzugriff (PDF)

Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells

Cancer immunology research, 2015-10, Vol.3 (10), p.1148-1157

2015

Volltextzugriff (PDF)

Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody

Proceedings of the National Academy of Sciences - PNAS, 2018-11, Vol.115 (47), p.12023-12027

2018

Volltextzugriff (PDF)

Neutrophils mediate antibody-induced antitumor effects in mice

Blood, 2013-10, Vol.122 (18), p.3160-3164

2013

Volltextzugriff (PDF)

Uninfected Bystander Cells Impact the Measurement of HIV-Specific Antibody-Dependent Cellular Cytotoxicity Responses

mBio, 2018-03, Vol.9 (2)

2018

Volltextzugriff (PDF)

Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure

Proceedings of the National Academy of Sciences - PNAS, 2011-05, Vol.108 (18), p.7505-7510

2011

Volltextzugriff (PDF)

New insights in Type I and II CD20 antibody mechanisms‐of‐action with a panel of novel CD20 antibodies

British journal of haematology, 2018-03, Vol.180 (6), p.808-820

2018

Volltextzugriff (PDF)

A Cetuximab-Mediated Suicide System in Chimeric Antigen Receptor-Modified Hematopoietic Stem Cells for Cancer Therapy

Human gene therapy, 2019-04, Vol.30 (4), p.413

2019

Volltextzugriff (PDF)

Enhanced ADCC and NK Cell Activation of an Anticarcinoma Bispecific Antibody by Genetic Insertion of a Modified IL-15 Cross-linker

Molecular therapy, 2016-08, Vol.24 (7), p.1312-1322

2016

Volltextzugriff (PDF)

Interaction between HLA-G and NK cell receptor KIR2DL4 orchestrates HER2-positive breast cancer resistance to trastuzumab

Signal transduction and targeted therapy, 2021-06, Vol.6 (1), p.236-236, Article 236

2021

Volltextzugriff (PDF)

KIR/HLA interactions negatively affect rituximab- but not GA101 (obinutuzumab)-induced antibody-dependent cellular cytotoxicity

The Journal of immunology (1950), 2014-06, Vol.192 (12), p.5618-5624

2014

Volltextzugriff (PDF)

Affinity-matured ‘aquaporumab’ anti-aquaporin-4 antibody for therapy of seropositive neuromyelitis optica spectrum disorders

Neuropharmacology, 2020-01, Vol.162, p.107827-107827, Article 107827

2020

Volltextzugriff (PDF)

The N-glycosylation of immunoglobulin G as a novel biomarker of Parkinson's disease

Glycobiology (Oxford), 2017-05, Vol.27 (5), p.501-510

2017

Volltextzugriff (PDF)

NK Cell and Ig Interplay in Defense against Herpes Simplex Virus Type 1: Epistatic Interaction of CD16A and IgG1 Allotypes of Variable Affinities Modulates Antibody-Dependent Cellular Cytotoxicity and Susceptibility to Clinical Reactivation

The Journal of immunology (1950), 2015-08, Vol.195 (4), p.1676-1684

2015

Volltextzugriff (PDF)

Immunoglobulin G Fragment C Receptor Polymorphisms and Clinical Efficacy of Trastuzumab-Based Therapy in Patients With HER-2/neu–Positive Metastatic Breast Cancer

Journal of clinical oncology, 2008-04, Vol.26 (11), p.1789-1796

2008

Volltextzugriff (PDF)

Terminal Effector CD8 T Cells Defined by an IKZF2 + IL-7R - Transcriptional Signature Express FcγRIIIA, Expand in HIV Infection, and Mediate Potent HIV-Specific Antibody-Dependent Cellular Cytotoxicity

The Journal of immunology (1950), 2019-10, Vol.203 (8), p.2210-2221

2019

Volltextzugriff (PDF)

Rituximab-dependent cytotoxicity by natural killer cells: Influence of FCGR3A polymorphism on the concentration-effect relationship

Cancer research (Chicago, Ill.), 2004-07, Vol.64 (13), p.4664-4669

2004

Volltextzugriff (PDF)

High-affinity CD16-polymorphism and Fc-engineered antibodies enable activity of CD16-chimeric antigen receptor-modified T cells for cancer therapy

British journal of cancer, 2019-01, Vol.120 (1), p.79-87

2019

Volltextzugriff (PDF)

The interplay of protein engineering and glycoengineering to fine‐tune antibody glycosylation and its impact on effector functions

Biotechnology and bioengineering, 2022-01, Vol.119 (1), p.102-117

2022

Volltextzugriff (PDF)

Promotion of cell proliferation and inhibition of ADCC by cancerous immunoglobulin expressed in cancer cell lines

Cellular & molecular immunology, 2012-01, Vol.9 (1), p.54-61

2012

Volltextzugriff (PDF)

Inhibition of WEE1 kinase and cell cycle checkpoint activation sensitizes head and neck cancers to natural killer cell therapies

Journal for immunotherapy of cancer, 2018-06, Vol.6 (1), p.59-12, Article 59

2018

Volltextzugriff (PDF)

A Mechanism of Resistance to Antibody-Targeted Immune Attack

Cancer immunology research, 2019-02, Vol.7 (2), p.230-243

2019

Volltextzugriff (PDF)

Bispecific antibodies for cancer therapy: The light at the end of the tunnel?

mAbs, 2009-11, Vol.1 (6), p.539-547

2009

Volltextzugriff (PDF)

Asymmetrical Fc Engineering Greatly Enhances Antibody-dependent Cellular Cytotoxicity (ADCC) Effector Function and Stability of the Modified Antibodies

The Journal of biological chemistry, 2014-02, Vol.289 (6), p.3571-3590

2014

Volltextzugriff (PDF)

An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer

The Journal of clinical investigation, 2010-09, Vol.120 (9), p.3234-3241

2010

Volltextzugriff (PDF)

1 – 25 von 1.281

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.199)
Mit Volltextzugriff
(1.085)

Publikationsform

Artikel
(1.280)
Buchkapitel
(1)

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

n.n

Thema

Science & Technology
(1.087)
Humans
(1.067)
Life Sciences & Biomedicine
(1.015)
Animals
(746)
Antibody-Dependent Cell Cytotoxicity
(717)
Mice
(509)
Immunology
(456)
Female
(352)
Biological And Medical Sciences
(330)
Killer Cells, Natural - Immunology
(303)
Antibody-Dependent Cell Cytotoxicity - Immunology
(293)
Oncology
(276)
Cell Line, Tumor
(260)
Cytotoxicity
(239)
Male
(223)
Medical Sciences
(205)
Immunotherapy
(201)
Antibodies, Monoclonal - Immunology
(191)
Antibodies
(182)
Receptors, Igg - Genetics
(163)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(1.272)
EZB Free E-Journals
(815)
IngentaConnect
(454)
RCN full-text journals@Ovid
(387)
NUS Single-Journal Subscriptions
(371)
IngentaConnect Journals
(259)
Elsevier ScienceDirect Journals Complete
(195)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(176)
Wiley-Blackwell Journals
(155)
Wiley Online Library
(124)
SpringerLink_现刊
(119)
Nature Journals
(78)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(70)
Nexis Uni
(67)
Taylor & Francis Journals
(66)
Taylor & Francis Journals Complete
(63)
Taylor & Francis
(59)
JSTOR Complete Journals
(47)
Oxford Journals
(41)
Oxford Journals 2020 Medicine
(23)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Immunology
(106)
The journal Of Immunology/the journal Of Immunology
(94)
Blood
(43)
Mabs
(36)
Journal Of Virology
(35)
Cancer Research
(33)
Clinical Cancer Research
(32)
Plos One
(30)
Proceedings Of The National Academy Of Sciences - Pnas
(28)
Frontiers In Immunology
(25)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)